Business Context and Reporting Period
This Form 6-K filing by GSK plc (GSK) reports a transaction in its own shares conducted on July 21, 2025. The report was filed on July 22, 2025. The transaction was executed through the corporate stockbroker, Merrill Lynch International, as part of the Company's existing share buyback programme under a non-discretionary agreement entered into on June 4, 2025.
Key Financial Metrics and Transaction Details
The filing details a specific repurchase event rather than full-period financial results. Key metrics for the transaction on July 21, 2025, include:
- Shares Purchased: 504,228 ordinary shares of 31½ pence each.
- Price Range: Lowest price paid was 1,337.00 GBp; highest price paid was 1,357.00 GBp.
- Average Price: Volume-weighted average price paid was 1,344.38 GBp.
- Trading Venue: All purchases occurred on the London Stock Exchange (XLON).
- Treasury Holdings: Following this purchase, GSK holds 233,321,695 ordinary shares in treasury.
- Shares in Issue: 4,082,062,585 ordinary shares (excluding Treasury shares).
- Voting Rights: Treasury shares represent 5.72% of total voting rights.
Material Changes and Programme Progress
Since the commencement of the current buyback agreement on June 4, 2025, the Company has purchased a total of 15,187,312 ordinary shares. The filing confirms that the purchased shares are held as Treasury shares. No other material changes to the Company's financial position, revenue, or debt levels are disclosed in this specific transaction report.
Guidance, Outlook, and Risks
This filing is a routine disclosure of a share repurchase and does not contain management commentary, forward-looking guidance, or new risk factors. The transaction was executed in accordance with the Disclosure Guidance and Transparency Rules (DTR 5.5.1R).
Important Facts for Investor Verification
- Verify the total number of shares purchased under the current buyback programme (15,187,312 since June 4, 2025).
- Confirm the updated treasury share count (233,321,695) and its impact on the denominator for shareholder notification thresholds (4,082,062,585 shares in issue).
- Note that the buyback is being executed via a non-discretionary agreement with Merrill Lynch International.
- Observe that the volume-weighted average price (1,344.38 GBp) falls within the reported daily trading range.